Is TP53 Mutated AML the Same Disease as TP53 Mutated MDS?

被引：0
|
作者：
Valk, Peter J. M. [1 ]
机构：
[1] Univ Med Ctr Rotterdam, Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
AML; MDS-EB; TP53; mutation; outcome; ALLELE FREQUENCY; MUTATIONS; OUTCOMES;
D O I：
10.1016/S2152-2650(22)00640-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S3 / S5
页数：3
相关论文
共 50 条
  • [41] Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes
    Montalban-Bravo, Guillermo
    Kanagal-Shamanna, Rashmi
    Benton, Christopher B.
    Class, Caleb A.
    Chien, Kelly S.
    Sasaki, Koji
    Naqvi, Kiran
    Alvarado, Yesid
    Kadia, Tapan M.
    Ravandi, Farhad
    Daver, Naval
    Takahashi, Koichi
    Jabbour, Elias
    Borthakur, Gautham
    Pemmaraju, Naveen
    Konopleva, Marina
    Soltysiak, Kelly A.
    Pierce, Sherry R.
    Bueso-Ramos, Carlos E.
    Patel, Keyur P.
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    BLOOD ADVANCES, 2020, 4 (03) : 482 - 495
  • [42] TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model
    Pabst, Gabriel
    Lind, Karin
    Graf, Ricarda
    Zebisch, Armin
    Stoelzel, Friedrich
    Doehner, Konstanze
    Heitzer, Ellen
    Reinisch, Andreas
    Sill, Heinz
    ANNALS OF HEMATOLOGY, 2020, 99 (03) : 653 - 655
  • [43] Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients
    Ferrari, Anna
    Fonzi, Eugenio
    Fontana, Maria Chiara
    Di Rora, Andrea Ghelli Luserna
    Manfrini, Marco
    Padella, Antonella
    Baldazzi, Carmen
    Papayannidis, Cristina
    Marconi, Giovanni
    Paolini, Stefania
    Guadagnuolo, Viviana
    Perricone, Margherita
    Robustelli, Valentina
    Imbrogno, Enrica
    Franchini, Eugenia
    Venturi, Claudia
    Zuffa, Elisa
    Abbenante, Maria Chiara
    Simonetti, Giorgia
    Testoni, Nicoletta
    Ottaviani, Emanuela
    Giovanni, Martinelli
    CANCER RESEARCH, 2017, 77
  • [44] TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model
    Gabriel Pabst
    Karin Lind
    Ricarda Graf
    Armin Zebisch
    Friedrich Stölzel
    Konstanze Döhner
    Ellen Heitzer
    Andreas Reinisch
    Heinz Sill
    Annals of Hematology, 2020, 99 : 653 - 655
  • [45] Clinical Impact Of Small TP53 Mutated Subclones In Chronic Lymphocytic Leukemia
    Rossi, Davide
    Khiabanian, Hossein
    Ciardullo, Carmela
    Spina, Valeria
    Bruscaggin, Alessio
    Fama, Rosella
    Monti, Sara
    Rasi, Silvia
    Wang, Jiguang
    Gattei, Valter
    Guarini, Anna
    FoA, Robin
    Rabadan, Raul
    Gaidano, Gianluca
    BLOOD, 2013, 122 (21)
  • [46] Nontransplant treat ment approaches for mye loid neoplasm with mutated TP53
    Mehta, Ansh K.
    Konopleva, Marina
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2024, (01) : 326 - 334
  • [47] Proteasome Hyperactivity as a Targetable Vulnerability in Oncogenic Missense TP53 Mutated NSCLC
    Oduah, E.
    Seetharamu, N.
    Litovchick, L.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E23 - E24
  • [48] Personalized Medicine for TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia
    Cluzeau, Thomas
    Loschi, Michael
    Fenaux, Pierre
    Komrokji, Rami
    Sallman, David A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (18)
  • [49] Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia
    Rossi, Davide
    Khiabanian, Hossein
    Spina, Valeria
    Ciardullo, Carmela
    Bruscaggin, Alessio
    Fama, Rosella
    Rasi, Silvia
    Monti, Sara
    Deambrogi, Clara
    De Paoli, Lorenzo
    Wang, Jiguang
    Gattei, Valter
    Guarini, Anna
    Foa, Robin
    Rabadan, Raul
    Gaidano, Gianluca
    BLOOD, 2014, 123 (14) : 2139 - 2147
  • [50] Carcinomatosis under control by osimertinib in EGFR and TP53 mutated lung adenocarcinoma
    Provenzano, Leonardo
    Cuccarini, Valeria
    Platania, Marco
    Canziani, Luca
    Spagnoletti, Andrea
    Doniselli, Fabio M.
    Eoli, Marica
    Prelaj, Arsela
    Anghileri, Elena
    TUMORI JOURNAL, 2021, 107 (06): : NP136 - NP140
12345